Trump announces plan to cut cost of weight loss drugs and expand access

Donald Trump has unveiled a new plan aimed at reducing the costs of weight loss drugs, specifically injectable GLP-1s from Eli Lilly and Novo Nordisk. This initiative is set to make these medications more affordable and accessible, particularly for patients relying on public health insurance. This move is significant as it addresses the rising costs of healthcare and aims to improve the quality of life for those struggling with weight management.